Molecular genetics of polycystic kidney disease

Journal of Nephrology

Volumn 11, Issue 1, 1998, Pages 24-34

  Calvet, James P ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cell differentiation; Cell proliferation; Loss of heterozygosity; Mutation; Protein protein interaction; Rodent models; Signal transduction; Transcription factor; Tuberous sclerosis; Two hit hypothesis

Indexed keywords

MEMBRANE PROTEIN; POLYCYSTIN 1; POLYCYSTIN 2; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; CELL DIFFERENTIATION; CELL INTERACTION; GENE EXPRESSION; GENE ISOLATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY POLYCYSTIC DISEASE; MOLECULAR GENETICS; PREDICTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MUTATION; POLYCYSTIC KIDNEY DISEASES; PROTEINS; TRPP CATION CHANNELS;

EID: 0031976449     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Watson ML, Torres WE, eds. Polycystic kidney disease. Oxford: Oxford University Press 1996.
2. Gabow PA, Grantham JJ. Polycystic kidney disease. In: Schrier RW, Gottschalk CW, eds. Diseases of the kidney. Boston: Little Brown, 1997; 521-60.
3. Welling LW, Grantham JJ. Cystic disease of the kidney. In: Tisher C, Brenner B, eds. Renal pathology. Philadelphia: Lippincott, 1996; 1828-63.
4. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329: 332-42.
5. Avner ED. Renal cystic disease. Insights from recent experimental investigations. Nephron 1988; 48: 89-93.
6. Gabow PA. Polycystic kidney disease: clues to pathogenesis. Kidney Int 1991; 40: 989-96.
7. Wilson PD, Sherwood AC. Tubulocystic epithelium. Kidney Int 1991; 39: 450-63.
8. Grantham JJ. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol 1993; 3: 1843-57.
9. Calvet JP. Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation? Kidney Int 1993; 43: 101-8.
10. Calvet JP. Injury and development in polycystic kidney disease. Curr Opin Nephrol Hypertens 1994; 3: 340-8.
11. Carone FA, Bacallao R, Kanwar YS. Biology of disease. Biology of polycystic kidney disease. Lab Invest 1994; 70: 437-48.
12. Grantham JJ. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. Am J Kidney Dis 1996; 28: 788-803.
13. Wilson PD. Epithelial cell polarity and disease. Am J Physiol 1997; 272: F434-42.
14. Grantham JJ. Polycystic kidney disease: neoplasia in disguise. Am J Kid Dis 1990; 15: 110-6.
15. Brill SR, Ross KE, Davidow CJ, Ye M, Grantham JJ, Caplan MJ. Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells. Proc Natl Acad Sci USA 1996; 93: 10206-11.
16. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995; 333: 18-25.
17. Lanoix J, D'Agati V, Szabolcs M, Trudel M. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disese (ADPKD). Oncogene 1996; 13: 1153-60.
18. Evan AP, McAteer JA. Cyst cells and cyst walls. In: Gardner KD, Bernstein J, eds. The cystic kidney. Boston: Kluwer, 1990; 21-41.
19. Grantham JJ, Geiser JL, Evan AP. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 1987; 31: 1145-52.
20. Germino GG, Reeders ST. A molecular approach to autosomal dominant polycystic kidney disease. In: Spitzer A, Avner E, eds. Inheritance of kidney and urinary tract diseases. Boston: Kluwer, 1990; 221-46.
21. Germino GG, Cloning strategies and genetics of type 1 autosomal dominant polycystic kidney disease. In: Watson ML, Torres VE, eds. Polycystic kidney disease. Oxford: Oxford University Press, 1996; 356-90.
22. Kaplan BS, Kaplan P. Autosomal recessive polycystic kidney disease. In: Spitzer A, Avner E, eds. Inheritance of kidney and urinary tract diseases. Boston: Kluwer, 1990; 265-76.
23. Guay-Woodford LM. Autosomal recessive polycystic kidney disease: clinical and genetic profiles. In: Watson ML, Torres VE, eds. Polycystic kidney disease. Oxford: Oxford University Press, 1996; 237-66.
24. The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994; 77: 881-94.
25. Burn TC, Connors TD, Dackowshi WR, et al. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. Hum Mol Genet 1995; 4: 575-82.
26. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995; 81: 289-98.
27. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nature Gen 1995; 10: 151-60.
28. Harris PC, Ward CJ, Peral B, Hughes J. Polycystic kidney disease 1: Identification and analysis of the primary defect. J Am Soc Nephrol 1995; 6: 1125-33.
29. Brook-Carter PT, Peral B, Ward CJ, et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - a contiguous gene syndrome. Nat Genet 1994; 8: 328-32.
30. Olsson PG, Lohning C, Horsley S, Kearney L, Harris PC, Frischauf A. The mouse homologue of the polycystic kidney disease gene (Pkd1) is a single-copy gene. Genomics 1996; 34: 233-5.
31. Sandford R, Sgotto B, Burn T, Brenner S. The tuberin (TSC2), autosomal dominant polycystic kidney disease (PKD1), and somatostatin type V receptor (SSTR5) genes form a synteny group in the Fugu genome. Genomics 1996; 38: 84-86.
32. Halley DJ. Tuberous sclerosis: between genetic and physical analysis. Acta Genet Med Gemellol (Roma) 1996; 45: 63-75.
33. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993; 18: 467-72.
34. Peters DJM, Spruit L, Saris JJ, et al. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nature Gen 1993; 5: 359-62.
35. Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-42.
36. Schneider MC, Rodriguez AM, Nomura H, Zhou J, Morton CC, Reeders ST, Weremowicz S. A gene similar to PKD1 maps to chromosome 4q22: a candidate gene for PKD2. Genomics 1996; 38: 1-4.
37. Daoust MC, Reynolds DM, Bichet DM, Somlo S. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 1995; 25: 733-6.
38. Turco AE, Clementi M, Rossetti S, Tenconi R, Pignatti PF. An Italian family with autosomal dominant polycystic kidney disease unlinked to either the PKD1 or PKD2 gene. Am J Kidney Dis 1996; 28: 759-61.
39. Zerres GM, Mucher G, Bachner L, et al. Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen. Nature Gen 1994; 7: 429-32.
40. Lens XM, Onuchic LF, Wu G, et al. An integrated genetic and physical map of the autosomal recessive polycystic kidney disease region. Genomics 1997; 41: 463-6.
41. Reeders ST. Multilocus polycystic kidney disease. Nature Gen 1992; 1: 235-7.
42. Hildebrandt F, Singh-Sawhney I, Schnieders B, Papenfuss T, Brandis M. Refined genetic mapping of a gene for familial juvenile nephronophthisis (NPH1) and physical mapping of linked markers. APN Study Group. Genomics 1995; 25: 360-4.
43. Groenen PM, Garcia E, Debeer P, Devriendt K, Fryns JP, Van de Ven WJ. Structure, sequence, and chromosome 19 localization of human USF2 and its rearrangement in a patient with multicystic renal dysplasia. Genomics 1996; 38: 141-8.
44. Feather SA, Woolf AS, Donnai D, Malcolm S, Winter RM. The oral-facial-digital syndrome type 1 (OFD1), a cause of polycystic kidney disease and associated malformations, maps to Xp22.2-Xp22.3. Hum Mol Genet 1997; 6: 1163-7.
45. Au KS, Murrell J, Buckler A, Blanton SH, Northrup H. Report of a critical recombination further narrowing the TSC1 region. J Med Genet 1996; 33: 559-61.
46. Au KS, Rodriguez JA, Rodriguez E Jr, Dobyns WB, Delgado MR, Northrup H. Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16. Hum Mutat 1997; 9: 23-9.
47. Decker HJ, Weidt EJ, Brieger J. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Cancer Genet Cytogenet 1997; 93: 74-83.
48. Sorenson CM, Padanilam BJ, Hammerman MR. Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse. Am J Physiol 1996; 271: F184-93.
49. Jena N, Martin-Seisdedos C, McCue P, Croce CM. BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res 1997; 230: 28-37.
50. Marker PC, King JA, Copeland NG, Jenkins NA, Kingsley DM. Chromosomal localization, embryonic expression, and imprinting tests for Bmp7 on distal mouse chromosome 2. Genomics 1995; 28: 576-80.
51. Yoder BK, Richards WG, Sweeney WE, Wilkinson JE, Avner ED, Woychik RP. Insertional mutagenesis and molecular analysis of a new gene associated with polycystic kidney disease. Proc Assoc Am Physicians 1995; 107: 314-23.
52. Trudel M, D'Agati V, Costantini F. c-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int 1991; 39: 665-71.
53. Trudel M, Chretien N, D'Agati V. Disappearance of polycystic kidney disease in revertant c-myc transgenic mice. Mamm Genome 1994; 5: 149-52.
54. MacKay K, Striker LJ, Pinkert CA, Brinster RL, Striker GE. Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int 1987; 32: 827-37.
55. Kelley KA, Aganral N, Reeders S, Herrup K. Renal cyst formation and multifocal neoplasia in transgenic mice carrying the Simiam Virus 40 early region. J Am Soc Nephrol 1991; 2: 84-97.
56. Dressler GR, Wilkinson JE, Rothenspieler UW, Patterson LT, Williams-Simons L, Westphal H. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 1993; 362: 65-7.
57. Schaffner DL, Barrios R, Massey C, et al. Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol 1993; 142: 1051-60.
58. Boulter CA, Aguzzi A, Evans MJ, Affara N. A chimaeric mouse model for autosomal-dominant polycystic kidney disease. Contrib Nephrol 1992; 97: 60-70.
59. Nguyen HQ, Danilenko DM, Bucay N, et al. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. Oncogene 1996; 12: 2109-19.
60. Lowden DA, Lindemann GW, Merlino G, Barash BD, Calvet JP, Gattone VH. Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med 1994; 124: 386-94.
61. Wanke R, Hermanns W, Folger S, Wolf E, Brem G. Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family: an overview. Pediatr Nephrol 1991; 5: 513-21.
62. Stocklin E, Botteri F, Groner B. An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice. J Cell Biol 1993; 122: 199-208.
63. Janaswami PM, Birkenmeier EH, Cook SA, Rowe LB, Bronson RT, Davisson MT. Identification and genetic mapping of a new polycystic kidney disease on mouse chromosome 8. Genomics 1997; 40: 101-7.
64. Nagao S, Watanabe T, Ogiso N, Marunouchi T, Takahashi H. Genetic mapping of the polycystic kidney gene, pcy, on mouse chromosome 9. Biochem Genet 1995; 33: 401-12.
65. Bryda EC, Ling H, Rathbun DE, Burmeiste M, Flaherty L. Fine genetic map of mouse chromosome 10 around the polycystic kidney disease gene, jcpk, and ankyrin 3. Genomics 1996; 35: 425-30.
66. Guay-Woodford LM, Bryda EC, Christine B, et al. Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic. Kidney Int 1996; 50: 1158-65.
67. Iakoubova OA, Dushkin H, Beier DR. Localization of a murine recessive polycystic kidney disease mutation and modifying loci that affect disease severity. Genomics 1995; 26: 107-14.
68. Davisson MT, Guay-Woodford LM, Harris HW, D'Eustachio P. The mouse polycystic kidney disease mutation (cpk) is located on proximal chromosome 12. Genomics 1991; 7: 778-81.
69. Cowley BD, Gudapaty S, Kraybill AL, Harding MA, Calvet JP, Gattone VH. Autosomal dominant polycystic kidney disease in the rat. Kidney Int 1993; 43: 522-34.
70. Nauta J, Goedbloed MA, Luider TM, Hoogeveen AT, van den Ouweland AM, Halley DJ. The Han: SPRD rat is not a genetic model of human autosomal dominant polycystic kidney disease type 1. Lab Anim 1997; 31: 241-7.
71. Bihoreau MT, Ceccherini I, Browne J, et al. Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han: SPRD cy/+ rat. Hum Mol Genet 1997; 6: 609-13.
72. Gattone VH. MacNaughton KA, Kraybill AL. Murine autosomal recessive polycystic kidney diseae with multiorgan involvement induced by the cpk gene. Anat Rec 1996; 245: 488-99.
73. McDonald RA, Avner ED. Mouse models of polycystic kidney disease. In: Watson ML, Torres VE, eds. Polycystic kidney disease. Oxford: Oxford University Press, 1996; 63-87.
74. Lohning C, Nowicka U, Frischauf AM. The mouse homolog of PKD1: sequence analysis and alternative splicing. Mamm Genome 1997; 8: 307-11.
75. Rossetti S, Bresin E, Restagno G, et al. Autosomal dominant polycystic kidney disease (ADPKD) in an Italian family carrying a novel nonsense mutation and two missense changes in exons 44 and 45 of the PKD1 Gene. Am J Med Genet 1996; 65: 155-9.
76. Neophytou P, Constantinides R, Lazarou A, Pierides A, Deltas CC. Detection of a novel nonsense mutation and an intragenic polymorphism in the PKD1 gene of a Cypriot family with autosomal dominant polycystic kidney disease. Hum Genet 1996; 98: 437-42.
77. Turco AE, Rossetti S, Bresin E, et al. Detection of two different nonsense mutations in exon 44 of the PKD1 gene in two unrelated Italian families with severe autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1996; 11 Suppl 6: 10-2.
78. Roelfsema JH, Peters DJ, Breuning MH. Detection of translation terminating mutations in the PKD1 gene. Nephrol Dial Transplant 1996; 11 Suppl 6: 5-9.
79. Peral B, San Millan JL, Ong AC, et al. Screening the 3′ region of the polycystic kidney disease 1 (PKD1) gene reveals six novel mutations. Am J Hum Genet 1996; 58: 86-96.
80. Turco AE, Rossetti S, Bresin E, et al. A novel nonsense mutation in the PKD1 gene (C3817T) is associated with autosomal dominant polycystic kidney disease (ADPKD) in a large three-generation Italian family. Hum Mol Genet 1995; 4: 1331-5.
81. Pearl B, Gamble V, San Millan JL, et al. Splicing mutations of the polycystic kidney disease 1 (PKD1) gene induced by intronic deletion. Hum Mol Genet 1995; 4: 569-74.
82. Gabow PA. Definition and natural history of autosomal dominant polycystic kidney disease. In: Watson ML, Torres VE, eds. Polycystic kidney disease. Oxford: Oxford University Press, 1996; 333-55.
83. Peral B, Ong AC, San Millan JL, Gamble V, Rees L, Harris PC. A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1). Hum Mol Genet 1996; 5: 539-42.
84. Parfrey PS, Culleton B. Management of end-stage renal failure and problems of transplantation in autosomal dominant polycystic kidney disease. In: Watson ML, Torres VE, eds. Polycystic kidney disease. Oxford: Oxford University Press, 1996; 450-61.
85. Peral B, Gamble V, Strong C, et al. Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet 1997; 60: 1399-410.
86. Xenophontos S, Constantinides R, Hayashi T, et al. A translation frameshift mutation induced by a cytosine in the polycystic kidney disease 2 gene. Hum Mol Genet 1997; 6: 949-52.
87. Veldhuisen B, Breuning MH, Wesby-van Swaay E, Boersma J, Peters DJ. Analysis of a large family with the second type of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1996; 11 Suppl 6: 13-7.
88. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney diseae type 1. Cell 1996; 87: 979-87.
89. Brasier JL, Henske EP. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest 1997; 99: 194-9.
90. Lohning C, Pohlschmidt M, Glucksmann-Kuis MA, et al. Structural motifs of the PKD1 protein. Nephrol Dial Transplant 1996; 11 Suppl 6: 2-4.
91. Moy GW, Mendoza LM, Schulz JR, Swanson WJ, Glable CG, Vacquier VD. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol 1996; 133: 809-17.
92. Kobe B, Deisenhofer J. The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci 1994; 19: 415-21.
93. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors. Ann Rev Biochem 1994; 63: 601-37.
94. Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino CG. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nature Gen 1997; 16: 179-83
95. Tsiokas L, Kim E, Arnould T, Sukhatme VP, Walz G. Homo-and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci USA 1997; 94: 6965-70.
96. Buaczynska MJ, Van Keuren ML, Buraczynska KM, Chang YS, Crombez E, Kurnit DM. Construction of human embryonic cDNA libraries: HD, PKD1 and BRCA1 are transcribed widely during embryogenesis. Cytogenet Cell Genet 1995; 71: 197-202.
97. Ward CJ, Turkey H, Ong AC, et al. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci USA 1996; 93: 1524-8.
98. Griffin MD, Torres VE, Grande JP, Kumar R. Immunolocalization of polycystin in human tissues and cultured cells. Proc Assoc Am Physicians 1996; 108: 185-97.
99. Peters DJ, Spruit L, Klingel R, et al. Adult, fetal, and polycystic kidney expression of polycystin, the polycystic kidney disease-1 gene product. Lab Invest 1996; 75: 221-30.
100. Palsson R, Sharma CP, Kim K, McLaughlin M, Brown D, Arnaout MA. Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol Med 1996; 2: 702-11.
101. Geng L, Segal Y, Peissel B, et al. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996; 98: 2674-82.
102. Gent L, Segal Y, Pavlova A, et al. Distribution and developmentally regulated expression of murine polycystin. Am J Physiol 1997; 272: F451-9.
103. Van Adelsberg J, Chamberlain S, D'Agati V. Polycystin expression is temporally and spatially regulated during renal development. Am J Physiol 1997; 272: F602-9.
104. Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, et al. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci USA 1997; 94: 6397-402.
105. Cowley BD, Smardo FL, Grantham JJ, Calvet JP. Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc Natl Acad Sci USA 1987; 84: 8394-8.
106. Gattone VH, Andrews GK, Fu-Wen N, Chadwick LJ, Klein RM, Calvet JP. Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Dev Biol 1990; 138: 225-30.
107. Cowley BD, Chadwick LJ, Grantham JJ, Calvet JP. Elevated proto-oncogene expression in polycystic kidneys of the C57B1/6J (cpk) mouse. J Am Soc Nephrol 1991; 1: 1048-53.
108. Harding MA, Chadwick LJ, Gattone VH, Calvet JP; The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease. Dev Biol 1991; 146: 483-90.
109. Rankin CA, Grantham JJ, Calvet JP. c-fos expression is hypersensitive to serum-stimulation in cultured cystic kidney cells from the C57BL/6J-cpk mouse. J Cell Physiol 1992; 152: 578-86.
110. Harding MA, Gattone VH, Grantham JJ, Calvet JP. Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse. Kidney Int 1992; 41: 317-25.
111. Maser RL, Magenheimer BS, Calvet JP. Mouse plasma glutathione peroxidase: cDNA sequence analysis and renal proximal tubule expression and secretion. J Biol Chem 1994; 269: 27066-73.
112. Aziz N, Maxwell M, St Jacques B, Brenner BM. Downregulation of Ke-6, a novel gene encoded within the major histocompatibility complex, in murine polycystic kidney disease. Mol Cell Biol 1993; 13: 1847-53.
113. Maxwell MM, Nearing J, Aziz N. Ke 6 gene. Sequence and organization and aberrant regulation in murine polycystic kidney disease. J Biol Chem 1995; 270: 25213-9.
114. Nakamura T, Ebihara I, Nagaoka I, et al. Growth factor gene expression in kidney of murine polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1378-86.
115. Rocco MV, Neilson EG, Hoyer JR, Ziyadeh FN. Attenuated expression of epithelial cell adhesion molecules in murine polycystic kidney disease. Am J Physiol 1992; 262: F679-86.
116. Schieren G, Gallone VH, Killen PD. Increased expression of extracellular matrix (ECM) genes occurs early in polycystic kidney disease (PKD) in CD1-pcy/pcy mice. J Am Soc Nephrol 1995; 6: 709.
117. Gallone VH, Maser RL. Altered expression of genes associated with renal concentration in murine polycystic kidney disease (PKD). J Am Soc Nephrol 1996; 7: 1596.
118. Maser RL, Magenheimer BS, Lindemann GW, Hou X, Rankin CA, Calvet JP. Identificalion of differenlially expressed cDNAs in lhe cystic kidneys of the C57BL/6J-cpk mouse. J Am Soc Nephrol 1993; 4: 817.
119. Falkenstein D, Burrow CR, Gatti L, Hartz P, Wilson PD. Expression of fetal proteins in human polycystic kidney disease (PKD) epithelia. J Am Soc Nephrol 1993; 4: 813.
120. Dressler GR, Deulsche U, Chowdhury K, Nornes HO. Gruss P. Pax-2, a new murine paired box containing gene and ils expression in the developing excretory system. Development 1990; 109: 787-95.
121. Dressler GR, Douglass EC. Pax-2 is a DNA binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 1992; 89: 1179-83.
122. Vanden Heuvel GB, Bodner R, McConnell KR, Nagami GT, Igarashi P. Expression of a cut-related homeobox gene in developing and polycystic mouse kidney. Kidney Int 1996; 50: 453-61.
123. Maser RL, Calvet JP. Androgen-responsive gene expression in kidney and submandibular gland of cyslic cpk mice. J Am Soc Nephrol 1993; 4: 817.
124. Magenheimer BS, Calvel JP. Altered expression of the mR-NAs for HNF-1α, HNF-1ß, and HNF-4 transcription factors in the cystic kidneys of the C57BL/6J-cpk mouse. J Am Soc Nephrol 1993; 4: 817.
125. Sladek FM. Orphan receptor HNF-4 and liver-specific gene expression. Receptor 1993; 3: 223-30.
126. Gregori C, Kahn A, Pichard AL. Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter. Nuc Acids Res 1993; 21: 897-903.
127. Patel YM, Yun JS, Liu J, McGrane MM, Hanson RW. An analysis of regulatory elements in the phosphoenolpyruvate carboxykinase (GTP) gene which are responsible for its tissue-specific expression and metabolic control in transgenic mice. J Biol Chem 1994; 269: 5619-28.
128. Xanthopoulos KG, Prezioso VR, Chen WS, Sladek FM, Cortese R, Darnell JE. The different tissue transcription patterns of genes for HNF-1, C/EBP, HNF-3, and HNF-4, protein factors that govern liver-specific transcription. Proc Natl Acad Sci USA 1991; 88: 3807-11.
129. Ott MO, Rey-Campos J, Cereghini S, Yaniv M. vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression. Mech Dev 1991; 36: 47-58.
130. Lazzaro D, De Simone V, De Magistris L, Lehtonen E, Cortese R. LFB1 and LFB3 homeoproteins are sequentially expressed during kidney development. Development 1992; 114:469-79.
131. Johnson P. Transcriptional activators in hepatocytes. Cell Growth Differ 1990; 1: 47-51.
132. Lai E, Darnell JE. Transcriptional control in hepatocytes: a window on development. Trends Biochem Sci 1991; 16: 427-30.
133. De Simone V, Cortese R. Transcriptional reuglation of liver-specific gene expression. Curr Opin Cell Biol 1991; 3: 960-5.
134. Tronche F, Yaniv M, HNF1, a homeoprotein member of the hepatic transcription regulatory network. BioEssays 1992; 14: 579-87.
135. Igarashi P. Transcription factors and apoptosis in kidney development. Curr Opin Nephrol Hypertens 1994; 3: 308-17.
136. Chen WS, Manova K, Weinstein DC, et al. Disruption of the HNF-4 gene, expressed in the visceral mesoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev 1994; 8: 2466-77.
137. Tian JM, Schibler U. Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes Dev 1991; 5: 2225-34.
138. Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE, Crabtree GR. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 1992; 355: 457-61.
139. Nitsch D, Boshart M, Schutz G. Extinction of tyrosine amino-transferase gene activity in somatic cell hybrids involves modification and loss of several essential transcriptional activators. Genes Dev 1993; 7: 308-19.
140. Pontoglio M, Barra J, Hadchouel M, et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 1996; 84: 575-85.